Translational medicine brings new diagnostic and prognostic biomarkers, as well as devices and therapeutics, to positively impact the lives of people at risk of cancer as well as patients with cancer. Translational research disease groups (TRDGs) coordinate assessment of research opportunities, particularly through investigator-initiated trials, interdisciplinary collaboration, research support, and trainee involvement.
MENU
Cancer Moonshot Summit
On Wednesday, June 29, 2016, Fox Chase Cancer Center hosted the official Cancer Moonshot Summit for the mid-Atlantic region featuring a live-streamed address by Vice President Joe Biden, and thought leaders in oncology brought together to discuss how to eradicate cancer. Learn more about the day’s events.
Clinical Research
The Office of Clinical Research at Fox Chase Cancer Center manages a significant portfolio of novel, therapeutic clinical trials sponsored by Fox Chase physician-scientists. Fox Chase participates in numerous trials sponsored by the NCI, as well as industry-sponsored and National Cooperative Group trials.